A detailed history of Summit Wealth Group LLC / CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Summit Wealth Group LLC / CO holds 1,717 shares of LLY stock, worth $1.76 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,717
Previous 774 121.83%
Holding current value
$1.76 Million
Previous $603 Million 52.87%
% of portfolio
0.31%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$625.65 - $812.69 $589,987 - $766,366
943 Added 121.83%
1,717 $922 Million
Q2 2025

Aug 13, 2025

BUY
$713.71 - $898.95 $552,411 - $695,787
774 New
774 $603 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $974B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Summit Wealth Group LLC / CO Portfolio

Follow Summit Wealth Group LLC / CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Wealth Group LLC / CO, based on Form 13F filings with the SEC.

News

Stay updated on Summit Wealth Group LLC / CO with notifications on news.